Alpha2A-adrenergic receptor and eNOS genetic polymorphisms are associated with exercise muscle vasodilatation in apparently healthy individuals

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Citação
IJC HEART & VASCULATURE, v.13, p.14-18, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: Muscle vasodilatation during exercise has been associated with cardiovascular health and may be influenced by genetic variability. The purpose of this study was to evaluate functional genetic polymorphisms of physiologic pathways related to the regulation of the cardiovascular function (alpha-adrenergic receptors, endothelial nitric oxide synthase and bradykinin B2 receptor) and exercise muscle vasodilatation in apparently healthymen and women. Methods: We enrolled 689 individuals without established cardiovascular disease that had attended a check-up program. The vasodilatation was studied with venous occlusion plethysmography and determined by the increase of vascular conductance during handgrip exercise. Genotypes for ADRA1A Arg347Cys (rs1048101), ADRA2A 1780 C > T (rs553668), ADRA2B Del 301-303 (rs28365031), eNOS 786 T > C (rs2070744), eNOS Glu298Asp (rs1799983) and BDKRB2 (rs5810761) polymorphisms were assessed by polymerase chain reaction followed by high resolution melting analysis. Results: The eNOS rs2070744 polymorphism was significantly associated with forearm vascular conductance during exercise in women. Women with CC genotype showed higher vasodilatation than carriers of TC and TT genotypes (p=0.043). The ADRA2A rs553668 polymorphism was significantly associated with forearm vascular conductance during exercise inmen. Men with TT genotype had higher vasodilatation than carriers of CT and CC genotypes (p=0.025). Conclusions: eNOS rs207074 polymorphism in women and ADRA2A rs553668 polymorphism in men were associated with the increase of forearm vascular conductance during handgrip exercise. These findings suggest that eNOS and ADRA2A genetic polymorphisms may be potential markers of exercise muscle vasodilatation. (C) 2016 The Authors.
Palavras-chave
Muscle vasodilatation, Forearm vascular conductance, Exercise, Genetic polymorphism, Alpha-adrenergic receptor, Endothelial nitric oxide synthase, Bradykinin B2 receptor, Cardiovascular genetics
Referências
  1. Alves CR, 2013, PHYSIOL GENOMICS, V45, P487, DOI 10.1152/physiolgenomics.00065.2012
  2. Barrett-O'Keefe Z, 2015, J GERONTOL A-BIOL, V70, P554, DOI 10.1093/gerona/glu065
  3. Nunes RAB, 2014, CARDIOLOGY, V127, P38, DOI 10.1159/000355157
  4. Casey DP, 2014, J APPL PHYSIOL, V116, P927, DOI 10.1152/japplphysiol.00409.2013
  5. Charkoudian N, 2001, CLIN AUTON RES, V11, P295, DOI 10.1007/BF02332974
  6. da Silva AG, 2008, PEDIATR EXERC SCI, V20, P157
  7. Dias RG, 2009, PHYSIOL GENOMICS, V37, P99, DOI 10.1152/physiolgenomics.90368.2008
  8. Dinenno FA, 2002, J PHYSIOL-LONDON, V540, P1103, DOI 10.1113/jphysiol.2001.015297
  9. Dosenko VE, 2006, ACTA BIOCHIM POL, V53, P299
  10. Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485
  11. Ingelsson E, 2008, J HUM HYPERTENS, V22, P569, DOI 10.1038/jhh.2008.37
  12. John S, 2000, AM J OBSTET GYNECOL, V183, P28, DOI 10.1067/mob.2000.105739
  13. Kneale BJ, 1997, CLIN SCI, V93, P513
  14. Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4
  15. KUBO SH, 1991, CIRCULATION, V84, P1589
  16. Kurnik D, 2011, CIRC-CARDIOVASC GENE, V4, P179, DOI 10.1161/CIRCGENETICS.110.957662
  17. Luzier AB, 1998, J CLIN PHARMACOL, V38, P618
  18. Matsuzawa Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000426
  19. Minson CT, 2000, CIRCULATION, V101, P862
  20. Nakayama M, 1999, CIRCULATION, V99, P2864
  21. Negrao CE, 2000, AM J PHYSIOL-HEART C, V278, pH168
  22. Negrao MV, 2010, PHYSIOL GENOMICS, V42A, P71, DOI 10.1152/physiolgenomics.00145.2009
  23. Nunes R.A., 2014, OPEN HEART, V1
  24. Proctor DN, 2004, MED SCI SPORT EXER, V36, P623, DOI 10.1249/01.MSS.0000121951.10417.B5
  25. Ribeiro MM, 2005, CIRCULATION, V111, P1915, DOI 10.1161/01.CIR.0000161959.04675.5A
  26. Richards JC, 2014, J PHYSIOL-LONDON, V592, P4775, DOI 10.1113/jphysiol.2014.278358
  27. Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827
  28. Rossi GP, 2006, J AM COLL CARDIOL, V48, P1166, DOI 10.1016/j.jacc.2006.05.046
  29. Rossi GP, 2003, J AM COLL CARDIOL, V41, P938, DOI 10.1016/S0735-1097(02)03011-5
  30. Saltin B, 1998, ACTA PHYSIOL SCAND, V162, P421, DOI 10.1046/j.1365-201X.1998.0293e.x
  31. Sartori Thiago E, 2010, Vasc Health Risk Manag, V6, P431
  32. Schmitt JAM, 2010, CLIN AUTON RES, V20, P271, DOI 10.1007/s10286-010-0061-y
  33. Suzuki K, 2008, ATHEROSCLEROSIS, V197, P212, DOI 10.1016/j.atherosclerosis.2007.03.023
  34. Trombetta IC, 2005, J APPL PHYSIOL, V98, P787, DOI 10.1152/japplphysiol.00503.2004
  35. Trombetta IC, 2003, AM J PHYSIOL-HEART C, V285, pH974, DOI 10.1152/ajpheart.01090.2002